Global and United States Regenerative Medicine Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 02-Sep-2021
No. of pages: 127
Inquire Before Buying

Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function". It is through the use of innovative medical means rebuilding diseased or damaged tissue or to support diseased or damaged tissue regeneration. The methods used include cell therapy, tissue engineering, chemically induced and therapeutic cloning, etc. Any combination of these technologies may be used to harness or stimulate the body's innate healing ability in order to treat a wide range of ailments, including musculoskeletal-related conditions, cardio- and peripheral vascular diseases, neurological disorders, stroke, non-healing wounds and ocular diseases.

Regenerative medicine is defined as the process of replacing or "regenerating" human cells, tissues or organs to restore or establish normal function and has been called the "next evolution of medical treatments" and "the vanguard of 21st century healthcare" by the U.S. Department of Health and Human Services.

Global Regenerative Medicine key players include J & J (DePuy Synthes), Medtronic, Allergan(Acelity), Zimmer Biomet, etc. Global top four manufacturers hold a share about 10%.

North America is the largest market, with a share about 25%, followed by Europe, and Asia Pacific, both have a share over 40 percent.

In terms of product, Tissue Engineering is the largest segment, with a share over 40%. And in terms of application, the largest application is Dermatology, followed by Cardiovascular, CNS, Orthopedic, etc.

Market Analysis and Insights: Global Regenerative Medicine Market

The global Regenerative Medicine market size is projected to reach US$ 95710 million by 2027, from US$ 28000 million in 2020, at a CAGR of 19.2% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Regenerative Medicine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Regenerative Medicine market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Regenerative Medicine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Regenerative Medicine market.

Global Regenerative Medicine Scope and Market Size

Regenerative Medicine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Regenerative Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Cell Therapy

- Tissue Engineering

- Biomaterial

- Other

Segment by Application

- Dermatology

- Cardiovascular

- CNS

- Orthopedic

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- J & J (DePuy Synthes)

- Medtronic

- Zimmer Biomet

- Stryker

- Allergan(Acelity)

- MiMedx Group

- Organogenesis

- Fujifilm Cellular Dynamics

- Osiris Therapeutics

- Vcanbio

- CCBC

- Cytori

- Celgene

- Vericel Corporation

- Guanhao Biotech

- Mesoblast

- AMAG Pharmaceuticals (CBR)

- ViaCord

- CordLife

- Integra LifeSciences

- Nuvasive

- Cook Biotech

- Japan Tissue Engineering

Global and United States Regenerative Medicine Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Regenerative Medicine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cell Therapy
1.2.3 Tissue Engineering
1.2.4 Biomaterial
1.2.5 Other
1.3 Market by Application
1.3.1 Global Regenerative Medicine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Dermatology
1.3.3 Cardiovascular
1.3.4 CNS
1.3.5 Orthopedic
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Regenerative Medicine Market Perspective (2016-2027)
2.2 Regenerative Medicine Growth Trends by Regions
2.2.1 Regenerative Medicine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Regenerative Medicine Historic Market Share by Regions (2016-2021)
2.2.3 Regenerative Medicine Forecasted Market Size by Regions (2022-2027)
2.3 Regenerative Medicine Industry Dynamic
2.3.1 Regenerative Medicine Market Trends
2.3.2 Regenerative Medicine Market Drivers
2.3.3 Regenerative Medicine Market Challenges
2.3.4 Regenerative Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Regenerative Medicine Players by Revenue
3.1.1 Global Top Regenerative Medicine Players by Revenue (2016-2021)
3.1.2 Global Regenerative Medicine Revenue Market Share by Players (2016-2021)
3.2 Global Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Regenerative Medicine Revenue
3.4 Global Regenerative Medicine Market Concentration Ratio
3.4.1 Global Regenerative Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Regenerative Medicine Revenue in 2020
3.5 Regenerative Medicine Key Players Head office and Area Served
3.6 Key Players Regenerative Medicine Product Solution and Service
3.7 Date of Enter into Regenerative Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Regenerative Medicine Breakdown Data by Type
4.1 Global Regenerative Medicine Historic Market Size by Type (2016-2021)
4.2 Global Regenerative Medicine Forecasted Market Size by Type (2022-2027)
5 Regenerative Medicine Breakdown Data by Application
5.1 Global Regenerative Medicine Historic Market Size by Application (2016-2021)
5.2 Global Regenerative Medicine Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Regenerative Medicine Market Size (2016-2027)
6.2 North America Regenerative Medicine Market Size by Type
6.2.1 North America Regenerative Medicine Market Size by Type (2016-2021)
6.2.2 North America Regenerative Medicine Market Size by Type (2022-2027)
6.2.3 North America Regenerative Medicine Market Size by Type (2016-2027)
6.3 North America Regenerative Medicine Market Size by Application
6.3.1 North America Regenerative Medicine Market Size by Application (2016-2021)
6.3.2 North America Regenerative Medicine Market Size by Application (2022-2027)
6.3.3 North America Regenerative Medicine Market Size by Application (2016-2027)
6.4 North America Regenerative Medicine Market Size by Country
6.4.1 North America Regenerative Medicine Market Size by Country (2016-2021)
6.4.2 North America Regenerative Medicine Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Regenerative Medicine Market Size (2016-2027)
7.2 Europe Regenerative Medicine Market Size by Type
7.2.1 Europe Regenerative Medicine Market Size by Type (2016-2021)
7.2.2 Europe Regenerative Medicine Market Size by Type (2022-2027)
7.2.3 Europe Regenerative Medicine Market Size by Type (2016-2027)
7.3 Europe Regenerative Medicine Market Size by Application
7.3.1 Europe Regenerative Medicine Market Size by Application (2016-2021)
7.3.2 Europe Regenerative Medicine Market Size by Application (2022-2027)
7.3.3 Europe Regenerative Medicine Market Size by Application (2016-2027)
7.4 Europe Regenerative Medicine Market Size by Country
7.4.1 Europe Regenerative Medicine Market Size by Country (2016-2021)
7.4.2 Europe Regenerative Medicine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Regenerative Medicine Market Size (2016-2027)
8.2 Asia-Pacific Regenerative Medicine Market Size by Type
8.2.1 Asia-Pacific Regenerative Medicine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Regenerative Medicine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Regenerative Medicine Market Size by Type (2016-2027)
8.3 Asia-Pacific Regenerative Medicine Market Size by Application
8.3.1 Asia-Pacific Regenerative Medicine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Regenerative Medicine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Regenerative Medicine Market Size by Application (2016-2027)
8.4 Asia-Pacific Regenerative Medicine Market Size by Region
8.4.1 Asia-Pacific Regenerative Medicine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Regenerative Medicine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Regenerative Medicine Market Size (2016-2027)
9.2 Latin America Regenerative Medicine Market Size by Type
9.2.1 Latin America Regenerative Medicine Market Size by Type (2016-2021)
9.2.2 Latin America Regenerative Medicine Market Size by Type (2022-2027)
9.2.3 Latin America Regenerative Medicine Market Size by Type (2016-2027)
9.3 Latin America Regenerative Medicine Market Size by Application
9.3.1 Latin America Regenerative Medicine Market Size by Application (2016-2021)
9.3.2 Latin America Regenerative Medicine Market Size by Application (2022-2027)
9.3.3 Latin America Regenerative Medicine Market Size by Application (2016-2027)
9.4 Latin America Regenerative Medicine Market Size by Country
9.4.1 Latin America Regenerative Medicine Market Size by Country (2016-2021)
9.4.2 Latin America Regenerative Medicine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Regenerative Medicine Market Size (2016-2027)
10.2 Middle East & Africa Regenerative Medicine Market Size by Type
10.2.1 Middle East & Africa Regenerative Medicine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Regenerative Medicine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Regenerative Medicine Market Size by Type (2016-2027)
10.3 Middle East & Africa Regenerative Medicine Market Size by Application
10.3.1 Middle East & Africa Regenerative Medicine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Regenerative Medicine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Regenerative Medicine Market Size by Application (2016-2027)
10.4 Middle East & Africa Regenerative Medicine Market Size by Country
10.4.1 Middle East & Africa Regenerative Medicine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Regenerative Medicine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 J & J (DePuy Synthes)
11.1.1 J & J (DePuy Synthes) Company Details
11.1.2 J & J (DePuy Synthes) Business Overview
11.1.3 J & J (DePuy Synthes) Regenerative Medicine Introduction
11.1.4 J & J (DePuy Synthes) Revenue in Regenerative Medicine Business (2016-2021)
11.1.5 J & J (DePuy Synthes) Recent Development
11.2 Medtronic
11.2.1 Medtronic Company Details
11.2.2 Medtronic Business Overview
11.2.3 Medtronic Regenerative Medicine Introduction
11.2.4 Medtronic Revenue in Regenerative Medicine Business (2016-2021)
11.2.5 Medtronic Recent Development
11.3 Zimmer Biomet
11.3.1 Zimmer Biomet Company Details
11.3.2 Zimmer Biomet Business Overview
11.3.3 Zimmer Biomet Regenerative Medicine Introduction
11.3.4 Zimmer Biomet Revenue in Regenerative Medicine Business (2016-2021)
11.3.5 Zimmer Biomet Recent Development
11.4 Stryker
11.4.1 Stryker Company Details
11.4.2 Stryker Business Overview
11.4.3 Stryker Regenerative Medicine Introduction
11.4.4 Stryker Revenue in Regenerative Medicine Business (2016-2021)
11.4.5 Stryker Recent Development
11.5 Allergan(Acelity)
11.5.1 Allergan(Acelity) Company Details
11.5.2 Allergan(Acelity) Business Overview
11.5.3 Allergan(Acelity) Regenerative Medicine Introduction
11.5.4 Allergan(Acelity) Revenue in Regenerative Medicine Business (2016-2021)
11.5.5 Allergan(Acelity) Recent Development
11.6 MiMedx Group
11.6.1 MiMedx Group Company Details
11.6.2 MiMedx Group Business Overview
11.6.3 MiMedx Group Regenerative Medicine Introduction
11.6.4 MiMedx Group Revenue in Regenerative Medicine Business (2016-2021)
11.6.5 MiMedx Group Recent Development
11.7 Organogenesis
11.7.1 Organogenesis Company Details
11.7.2 Organogenesis Business Overview
11.7.3 Organogenesis Regenerative Medicine Introduction
11.7.4 Organogenesis Revenue in Regenerative Medicine Business (2016-2021)
11.7.5 Organogenesis Recent Development
11.8 Fujifilm Cellular Dynamics
11.8.1 Fujifilm Cellular Dynamics Company Details
11.8.2 Fujifilm Cellular Dynamics Business Overview
11.8.3 Fujifilm Cellular Dynamics Regenerative Medicine Introduction
11.8.4 Fujifilm Cellular Dynamics Revenue in Regenerative Medicine Business (2016-2021)
11.8.5 Fujifilm Cellular Dynamics Recent Development
11.9 Osiris Therapeutics
11.9.1 Osiris Therapeutics Company Details
11.9.2 Osiris Therapeutics Business Overview
11.9.3 Osiris Therapeutics Regenerative Medicine Introduction
11.9.4 Osiris Therapeutics Revenue in Regenerative Medicine Business (2016-2021)
11.9.5 Osiris Therapeutics Recent Development
11.10 Vcanbio
11.10.1 Vcanbio Company Details
11.10.2 Vcanbio Business Overview
11.10.3 Vcanbio Regenerative Medicine Introduction
11.10.4 Vcanbio Revenue in Regenerative Medicine Business (2016-2021)
11.10.5 Vcanbio Recent Development
11.11 CCBC
11.11.1 CCBC Company Details
11.11.2 CCBC Business Overview
11.11.3 CCBC Regenerative Medicine Introduction
11.11.4 CCBC Revenue in Regenerative Medicine Business (2016-2021)
11.11.5 CCBC Recent Development
11.12 Cytori
11.12.1 Cytori Company Details
11.12.2 Cytori Business Overview
11.12.3 Cytori Regenerative Medicine Introduction
11.12.4 Cytori Revenue in Regenerative Medicine Business (2016-2021)
11.12.5 Cytori Recent Development
11.13 Celgene
11.13.1 Celgene Company Details
11.13.2 Celgene Business Overview
11.13.3 Celgene Regenerative Medicine Introduction
11.13.4 Celgene Revenue in Regenerative Medicine Business (2016-2021)
11.13.5 Celgene Recent Development
11.14 Vericel Corporation
11.14.1 Vericel Corporation Company Details
11.14.2 Vericel Corporation Business Overview
11.14.3 Vericel Corporation Regenerative Medicine Introduction
11.14.4 Vericel Corporation Revenue in Regenerative Medicine Business (2016-2021)
11.14.5 Vericel Corporation Recent Development
11.15 Guanhao Biotech
11.15.1 Guanhao Biotech Company Details
11.15.2 Guanhao Biotech Business Overview
11.15.3 Guanhao Biotech Regenerative Medicine Introduction
11.15.4 Guanhao Biotech Revenue in Regenerative Medicine Business (2016-2021)
11.15.5 Guanhao Biotech Recent Development
11.16 Mesoblast
11.16.1 Mesoblast Company Details
11.16.2 Mesoblast Business Overview
11.16.3 Mesoblast Regenerative Medicine Introduction
11.16.4 Mesoblast Revenue in Regenerative Medicine Business (2016-2021)
11.16.5 Mesoblast Recent Development
11.17 AMAG Pharmaceuticals (CBR)
11.17.1 AMAG Pharmaceuticals (CBR) Company Details
11.17.2 AMAG Pharmaceuticals (CBR) Business Overview
11.17.3 AMAG Pharmaceuticals (CBR) Regenerative Medicine Introduction
11.17.4 AMAG Pharmaceuticals (CBR) Revenue in Regenerative Medicine Business (2016-2021)
11.17.5 AMAG Pharmaceuticals (CBR) Recent Development
11.18 ViaCord
11.18.1 ViaCord Company Details
11.18.2 ViaCord Business Overview
11.18.3 ViaCord Regenerative Medicine Introduction
11.18.4 ViaCord Revenue in Regenerative Medicine Business (2016-2021)
11.18.5 ViaCord Recent Development
11.18 CordLife
.1 CordLife Company Details
.2 CordLife Business Overview
.3 CordLife Regenerative Medicine Introduction
.4 CordLife Revenue in Regenerative Medicine Business (2016-2021)
.5 CordLife Recent Development
11.20 Integra LifeSciences
11.20.1 Integra LifeSciences Company Details
11.20.2 Integra LifeSciences Business Overview
11.20.3 Integra LifeSciences Regenerative Medicine Introduction
11.20.4 Integra LifeSciences Revenue in Regenerative Medicine Business (2016-2021)
11.20.5 Integra LifeSciences Recent Development
11.21 Nuvasive
11.21.1 Nuvasive Company Details
11.21.2 Nuvasive Business Overview
11.21.3 Nuvasive Regenerative Medicine Introduction
11.21.4 Nuvasive Revenue in Regenerative Medicine Business (2016-2021)
11.21.5 Nuvasive Recent Development
11.22 Cook Biotech
11.22.1 Cook Biotech Company Details
11.22.2 Cook Biotech Business Overview
11.22.3 Cook Biotech Regenerative Medicine Introduction
11.22.4 Cook Biotech Revenue in Regenerative Medicine Business (2016-2021)
11.22.5 Cook Biotech Recent Development
11.23 Japan Tissue Engineering
11.23.1 Japan Tissue Engineering Company Details
11.23.2 Japan Tissue Engineering Business Overview
11.23.3 Japan Tissue Engineering Regenerative Medicine Introduction
11.23.4 Japan Tissue Engineering Revenue in Regenerative Medicine Business (2016-2021)
11.23.5 Japan Tissue Engineering Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Regenerative Medicine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cell Therapy
Table 3. Key Players of Tissue Engineering
Table 4. Key Players of Biomaterial
Table 5. Key Players of Other
Table 6. Global Regenerative Medicine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Regenerative Medicine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Regenerative Medicine Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Regenerative Medicine Market Share by Regions (2016-2021)
Table 10. Global Regenerative Medicine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Regenerative Medicine Market Share by Regions (2022-2027)
Table 12. Regenerative Medicine Market Trends
Table 13. Regenerative Medicine Market Drivers
Table 14. Regenerative Medicine Market Challenges
Table 15. Regenerative Medicine Market Restraints
Table 16. Global Regenerative Medicine Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Regenerative Medicine Market Share by Players (2016-2021)
Table 18. Global Top Regenerative Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Regenerative Medicine as of 2020)
Table 19. Ranking of Global Top Regenerative Medicine Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Regenerative Medicine Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Regenerative Medicine Product Solution and Service
Table 23. Date of Enter into Regenerative Medicine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Regenerative Medicine Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Regenerative Medicine Revenue Market Share by Type (2016-2021)
Table 27. Global Regenerative Medicine Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Regenerative Medicine Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Regenerative Medicine Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Regenerative Medicine Revenue Market Share by Application (2016-2021)
Table 31. Global Regenerative Medicine Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Regenerative Medicine Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Regenerative Medicine Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Regenerative Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Regenerative Medicine Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Regenerative Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Regenerative Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Regenerative Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Regenerative Medicine Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Regenerative Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Regenerative Medicine Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Regenerative Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Regenerative Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Regenerative Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Regenerative Medicine Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Regenerative Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Regenerative Medicine Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Regenerative Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Regenerative Medicine Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Regenerative Medicine Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Regenerative Medicine Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Regenerative Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Regenerative Medicine Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Regenerative Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Regenerative Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Regenerative Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Regenerative Medicine Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Regenerative Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Regenerative Medicine Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Regenerative Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Regenerative Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Regenerative Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 63. J & J (DePuy Synthes) Company Details
Table 64. J & J (DePuy Synthes) Business Overview
Table 65. J & J (DePuy Synthes) Regenerative Medicine Product
Table 66. J & J (DePuy Synthes) Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 67. J & J (DePuy Synthes) Recent Development
Table 68. Medtronic Company Details
Table 69. Medtronic Business Overview
Table 70. Medtronic Regenerative Medicine Product
Table 71. Medtronic Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 72. Medtronic Recent Development
Table 73. Zimmer Biomet Company Details
Table 74. Zimmer Biomet Business Overview
Table 75. Zimmer Biomet Regenerative Medicine Product
Table 76. Zimmer Biomet Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 77. Zimmer Biomet Recent Development
Table 78. Stryker Company Details
Table 79. Stryker Business Overview
Table 80. Stryker Regenerative Medicine Product
Table 81. Stryker Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 82. Stryker Recent Development
Table 83. Allergan(Acelity) Company Details
Table 84. Allergan(Acelity) Business Overview
Table 85. Allergan(Acelity) Regenerative Medicine Product
Table 86. Allergan(Acelity) Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 87. Allergan(Acelity) Recent Development
Table 88. MiMedx Group Company Details
Table 89. MiMedx Group Business Overview
Table 90. MiMedx Group Regenerative Medicine Product
Table 91. MiMedx Group Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 92. MiMedx Group Recent Development
Table 93. Organogenesis Company Details
Table 94. Organogenesis Business Overview
Table 95. Organogenesis Regenerative Medicine Product
Table 96. Organogenesis Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 97. Organogenesis Recent Development
Table 98. Fujifilm Cellular Dynamics Company Details
Table 99. Fujifilm Cellular Dynamics Business Overview
Table 100. Fujifilm Cellular Dynamics Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 101. Fujifilm Cellular Dynamics Recent Development
Table 102. Osiris Therapeutics Company Details
Table 103. Osiris Therapeutics Business Overview
Table 104. Osiris Therapeutics Regenerative Medicine Product
Table 105. Osiris Therapeutics Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 106. Osiris Therapeutics Recent Development
Table 107. Vcanbio Company Details
Table 108. Vcanbio Business Overview
Table 109. Vcanbio Regenerative Medicine Product
Table 110. Vcanbio Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 111. Vcanbio Recent Development
Table 112. CCBC Company Details
Table 113. CCBC Business Overview
Table 114. CCBC Regenerative Medicine Product
Table 115. CCBC Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 116. CCBC Recent Development
Table 117. Cytori Company Details
Table 118. Cytori Business Overview
Table 119. Cytori Regenerative Medicine Product
Table 120. Cytori Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 121. Cytori Recent Development
Table 122. Celgene Company Details
Table 123. Celgene Business Overview
Table 124. Celgene Regenerative Medicine Product
Table 125. Celgene Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 126. Celgene Recent Development
Table 127. Vericel Corporation Company Details
Table 128. Vericel Corporation Business Overview
Table 129. Vericel Corporation Regenerative Medicine Product
Table 130. Vericel Corporation Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 131. Vericel Corporation Recent Development
Table 132. Guanhao Biotech Company Details
Table 133. Guanhao Biotech Business Overview
Table 134. Guanhao Biotech Regenerative Medicine Product
Table 135. Guanhao Biotech Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 136. Guanhao Biotech Recent Development
Table 137. Mesoblast Company Details
Table 138. Mesoblast Business Overview
Table 139. Mesoblast Regenerative Medicine Product
Table 140. Mesoblast Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 141. Mesoblast Recent Development
Table 142. AMAG Pharmaceuticals (CBR) Company Details
Table 143. AMAG Pharmaceuticals (CBR) Business Overview
Table 144. AMAG Pharmaceuticals (CBR) Regenerative Medicine Product
Table 145. AMAG Pharmaceuticals (CBR) Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 146. AMAG Pharmaceuticals (CBR) Recent Development
Table 147. ViaCord Company Details
Table 148. ViaCord Business Overview
Table 149. ViaCord Regenerative Medicine Product
Table 150. ViaCord Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 151. ViaCord Recent Development
Table 152. CordLife Company Details
Table 153. CordLife Business Overview
Table 154. CordLife Regenerative Medicine Product
Table 155. CordLife Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 156. CordLife Recent Development
Table 157. Integra LifeSciences Company Details
Table 158. Integra LifeSciences Business Overview
Table 159. Integra LifeSciences Regenerative Medicine Product
Table 160. Integra LifeSciences Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 161. Integra LifeSciences Recent Development
Table 162. Nuvasive Company Details
Table 163. Nuvasive Business Overview
Table 164. Nuvasive Regenerative Medicine Product
Table 165. Nuvasive Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 166. Nuvasive Recent Development
Table 167. Cook Biotech Company Details
Table 168. Cook Biotech Business Overview
Table 169. Cook Biotech Regenerative Medicine Product
Table 170. Cook Biotech Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 171. Cook Biotech Recent Development
Table 172. Japan Tissue Engineering Company Details
Table 173. Japan Tissue Engineering Business Overview
Table 174. Japan Tissue Engineering Regenerative Medicine Product
Table 175. Japan Tissue Engineering Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 176. Japan Tissue Engineering Recent Development
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Regenerative Medicine Market Share by Type: 2020 VS 2027
Figure 2. Cell Therapy Features
Figure 3. Tissue Engineering Features
Figure 4. Biomaterial Features
Figure 5. Other Features
Figure 6. Global Regenerative Medicine Market Share by Application: 2020 VS 2027
Figure 7. Dermatology Case Studies
Figure 8. Cardiovascular Case Studies
Figure 9. CNS Case Studies
Figure 10. Orthopedic Case Studies
Figure 11. Others Case Studies
Figure 12. Regenerative Medicine Report Years Considered
Figure 13. Global Regenerative Medicine Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Regenerative Medicine Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Regenerative Medicine Market Share by Regions: 2020 VS 2027
Figure 16. Global Regenerative Medicine Market Share by Regions (2022-2027)
Figure 17. Global Regenerative Medicine Market Share by Players in 2020
Figure 18. Global Top Regenerative Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Regenerative Medicine as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Regenerative Medicine Revenue in 2020
Figure 20. Global Regenerative Medicine Revenue Market Share by Type (2016-2021)
Figure 21. Global Regenerative Medicine Revenue Market Share by Type (2022-2027)
Figure 22. North America Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Regenerative Medicine Market Share by Type (2016-2027)
Figure 24. North America Regenerative Medicine Market Share by Application (2016-2027)
Figure 25. North America Regenerative Medicine Market Share by Country (2016-2027)
Figure 26. United States Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Regenerative Medicine Market Share by Type (2016-2027)
Figure 30. Europe Regenerative Medicine Market Share by Application (2016-2027)
Figure 31. Europe Regenerative Medicine Market Share by Country (2016-2027)
Figure 32. Germany Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Regenerative Medicine Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Regenerative Medicine Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Regenerative Medicine Market Share by Region (2016-2027)
Figure 42. China Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Regenerative Medicine Market Share by Type (2016-2027)
Figure 50. Latin America Regenerative Medicine Market Share by Application (2016-2027)
Figure 51. Latin America Regenerative Medicine Market Share by Country (2016-2027)
Figure 52. Mexico Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Regen
  • Global Tissue Engineered Skin Substitutes Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global Tissue Engineered Skin Substitutes market was valued at US$ 1571.8 million in 2023 and is anticipated to reach US$ 3109.6 million by 2030, witnessing a CAGR of 9.8% during The forecast period 2024-2030. North American market for Tissue Engineered Skin Substitutes is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Tissue Engineered Skin Substitutes is est......
  • Global Tissue Engineering Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Tissue Engineering market size was valued at US$ 26430 million in 2023. With growing demand in downstream market, the Tissue Engineering is forecast to a readjusted size of US$ 90330 million by 2030 with a CAGR of 19.2% during review period. The research report highlights the growth potential of the global Tissue Engineering market. Tissue Engineering are expected to show stable growth in the future market. However, product d......
  • Global Regenerative Medicine Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 150
    According to our LPI (LP Information) latest study, the global Regenerative Medicine market size was valued at US$ 32640 million in 2023. With growing demand in downstream market, the Regenerative Medicine is forecast to a readjusted size of US$ 116410 million by 2030 with a CAGR of 19.9% during review period. The research report highlights the growth potential of the global Regenerative Medicine market. Regenerative Medicine are expected to show stable growth in the future market. Howev......
  • Global Tissue Engineered Skin Substitutes Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 108
    Market Overview of Global Tissue Engineered Skin Substitutes market: According to our latest research, the global Tissue Engineered Skin Substitutes market looks promising in the next 5 years. As of 2022, the global Tissue Engineered Skin Substitutes market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Tissue-engineered skin substitutes have become viable as a suitable alternative to auto- ......
  • Regenerative Medicine Products - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 121
    The global Regenerative Medicine Products market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Regenerative Medicine Products in various end use industries. The expanding demands from the Dermatology, Cardiovascular, CNS and Orthopedic, are propelling Regenerative Medicine Products market. Cell Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ ......
  • Tissue Engineered Skin Substitutes - Global Market Insights and Sales Trends 2024
    Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 96
    The global Tissue Engineered Skin Substitutes market size is expected to reach US$ 3109.6 million by 2029, growing at a CAGR of 9.8% from 2023 to 2029. The market is mainly driven by the significant applications of Tissue Engineered Skin Substitutes in various end use industries. The expanding demands from the Burn Injury, Diabetic, Vascular Ulcer and Others, are propelling Tissue Engineered Skin Substitutes market. Acellular, one of the segments analysed in this report, is projected to record %......
  • Global Tissue Engineering and Regeneration Market Research Report 2023
    Published: 21-Nov-2023        Price: US 2900 Onwards        Pages: 98
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Tissue Engineering and Regeneration market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Advanced Cell Technology - Ocata Therapeutics - Arteriocyte - Therapeutics - BioTissue Technologies - Kinetic Concepts - Bi......
  • Global Tissue Analysis Products Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 09-Nov-2023        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Tissue Analysis Products market: According to our latest research, the global Tissue Analysis Products market looks promising in the next 5 years. As of 2022, the global Tissue Analysis Products market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global......
  • Regenerative Medicine Collaboration and Licensing Deals 2016-2023
    Published: 01-Nov-2023        Price: US 3995 Onwards        Pages: 950
    Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the regenerative medicine deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of regenerative medicine deals from 2016 to 2023. The report provides a detailed understanding and analysis of how and why companies enter regenerative medicine deals. These deals tend to be multicomponent, s......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs